Aerosol delivery of liposome-encapsulated ciprofloxacin: Aerosol characterization and efficacy against Francisella tularensis infection in mice

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1288-1292

  Conley, John ^a   Yang, Huiming ^b   Wilson, Tammy ^a   Blasetti, Karen ^b   Di Ninno, Vincent ^a   Schnell, Glen ^b   Wong, Jonathan Park ^b,c  

^a SciLab Consulting Inc   (Canada)

^b CFB Suffield   (Canada)

^c Box 4000   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LIPOSOME;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FRANCISELLA TULARENSIS; INTRANASAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT; LUNG INFECTION; MOUSE; NEBULIZER; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0030997918     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1288     Document Type: Article

References (30)

1. Atmar, R. L., S. B. Greenberg, J. M. Quarles, S. Z. Wilson, S. Feldman, and R. B. Couch. 1900. Safety and pharmacokinetics of rimantidine small-particle aerosol. Antimicrob. Agents Chemother. 34:2228-2233.
2. Bergogne-Bérézin, E. 1993. Pharmacokinetics of fluoroquinolones in the respiratory tissues and fluids. Quinolones Bull. 10:1-18.
3. Chin, N. X., and H. C. Neu. 1984. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 25:319-326.
4. Clarke, S. W., and S. P. Newman. 1984. Therapeutic aerosols. II. Drugs available by the inhaled route. Thorax 39:1-7.
5. Debs, R. J., R. M. Straubinger, E. N. Brunette, J. M. Lin, E. J. Lin, A. B. Montgomery, D. S. Friend, and D. P. Papahadjopoulos. 1987. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. Am. Rev. Respir. Dis. 135:731-737.
6. Di Ninno, V. L., J. W. Cherwonogrodzky, and J. P. Wong. 1993. Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis. J. Infect. Dis. 168:793-794.
7. 99mTechnetium as a marker of liposomal deposition and clearance in the human lung. Int. J. Pharm. 26:303-316.
8. Fenlon, C. H., and M. H. Cynamon. 1986. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob. Agents Chemother. 29:386-388.
9. Fortier, A. H., M. V. Slayter, R. Ziemba, M. S. Meltzer, and C. A. Nacy. 1991. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:2922-2928.
10. Gay, J. D., D. R. De Young, and G. D. Roberts. 1984. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob. Agents Chemother. 26:94-96.
11. Gilbert, B. E., R. Six II, S. Z. Wilson, P. R. Wyde, arid V. Knight. 1987. Small particle aerosols of enviroximine-containing liposomes. Antiviral Res. 9:355-365.
12. Gilbert, B. E., P. R. Wyde, and S. Z. Wilson. 1992. Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice. Antimicrob. Agents Chemother. 36:1466-1471.
13. Gonzalez-Rothi, R. J., J. Cacace, L. Straub, and H. Schreier. 1991. Liposomes and pulmonary alveolar macrophages: function and morphological interactions. Exp. Lung Res. 17:687-705.
14. Heifets, L. B., and P. J. Lindholm-Levy. 1987. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68:267-276.
15. Hodson, M., A. Penketh, and J. C. Batten. 1981. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet ii:1137-1139.
16. Knight, V., C. P. Yu, B. E. Gilbert, and G. W. Divine. 1988. Estimating dose of ribavarin aerosol according to age and other variables. J. Infect. Dis. 158:443-448.
17. Magallanes, M., J. Dijkstra, and J. Ferrer. 1993. Liposome-incorporated ciprofloxacin in the treatment of murine salmonellosis. Antimicrob. Agents Chemother. 37:2293-2297.
18. Mehta, R. T., A. Keyhani, T. J. McQueen, B. Rosenbaum, K. V. Rolston, and J. J. Tarrand. 1993. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob. Agents Chemother. 37:2584-2587.
19. Montgomery, A. B., R. J. Debs, J. M. Luce, K. J. Corkery, T. Turner, E. N. Brunette, E. T. Lin, and P. C. Hopewell. 1988. Selective delivery of pentamidine to the lung by aerosol. Am. Rev. Respir. Dis. 137:477-478.
20. O'Doherty, M. J., C. Page, C. Bradbeer, S. Thomas, D. Barlow, T. O. Nunan, and N. T. Bateman. 1988. Differences in relative of nebulizers for pentamidine administration. Lancet ii:1283-1286.
21. Oh, Y.-K., D. E. Nix, and R. B. Straubinger. 1995. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob. Agents Chemother. 39:2104-2111.
22. Quentin, R., N. Koubaa, B. Cattier, M. Gavignet, and A. Goudeau. 1988. In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates. Antimicrob. Agents Chemother. 32:147-149.
23. Rao, S., D. B. Wilson, R. C. Brooks, and B. J. Sproule. 1970. Acute effects of nebulization of N-acetyl-cysteine on pulmonary mechanics and gas exchange. Am. Rev. Respir. Dis. 102:17-22.
24. Roy, C., A. Foz, C. Segura, M. Tirado, M. Teixell, et al. 1983. Activity of ciprofloxacin (BAY 0 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae. Infection 11:326-328.
25. Shek, P. N., and R. F. Barber. 1990. Liposomes for pulmonary applications. Mod. Med. 45:135-141.
26. Taylor, K. M. G., G. Taylor, I. W. Kellaway, and J. Stevens. 1989. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm. Res. 6:633-641.
27. Waldrep, J. C., K. Keyhani, M. Black, and V. Knight. 1994. Operating characteristics of 18 different continuous-flow jet nebulizers with becla-methasone dipropionate liposome aerosol. Chest 105:106-110.
28. Wiehert, B. V., R. J. Gonzalez-Rothi, L. E. Straub, B. M. Wiehert, and H. Schreier. 1992. Amikacin liposomes: characterization, aerosolization, and in vitro activity against Mycobacterium avium-intracellulare in alveolar macrophages. Int. J. Pharm. 78:227-235.
29. Wong, J. P., E. G. Saravolac, and L. L. Stadnyk. 1994. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody. Immunology 81:280-284.
30. Wong, J. P., J. W. Cherwonogrodzky, V. L. Di Ninno, R. Dela Cruz, and E. G. Saravolac. 1995. Liposome-encapsulated ciprofloxacin for the prevention and treatment of infectious diseases caused by intracellular pathogens, p. 105-120. In A. T. Florence and G. Gregoriadis (ed.), Liposomes in biomedical applications. Harwood Academic Press, Amsterdam, The Netherlands.